The dose tracking copilot market size has grown rapidly in recent years. It will grow from $1.36 billion in 2025 to $1.6 billion in 2026 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to rise in chronic disease management, medication non-adherence issues, growth in digital health apps, hospital digitization, expansion of diagnostic imaging.
The dose tracking copilot market size is expected to see rapid growth in the next few years. It will grow to $2.99 billion in 2030 at a compound annual growth rate (CAGR) of 17%. The growth in the forecast period can be attributed to AI-driven clinical decision support, remote patient management growth, regulatory focus on dose monitoring, personalized treatment pathways, cloud-based healthcare platforms. Major trends in the forecast period include medication adherence monitoring, intelligent dose reminder systems, real-time dose analytics, patient-centric digital health tools, integration with wearables.
The increasing prevalence of chronic diseases is expected to propel the growth of the dose tracking copilot market going forward. Chronic diseases are long-lasting health conditions that usually progress slowly over time, such as diabetes, heart disease, and arthritis, and often require ongoing medical attention and lifestyle management to control symptoms and prevent complications. Chronic diseases are rising largely due to unhealthy lifestyles, including poor diet, physical inactivity, and smoking, which increase the risk of conditions such as diabetes, heart disease, and obesity. Dose tracking copilot supports chronic disease management by providing real-time monitoring and personalized dose reminders, making it suitable for patients with complex medication schedules. It reduces the risk of missed or incorrect doses by enabling accurate adherence tracking, improving treatment effectiveness and overall patient outcomes. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing prevalence of chronic diseases is driving the growth of the dose tracking copilot market.
The rising adoption of electronic health records (EHRs) is expected to propel the growth of the dose tracking copilot market going forward. Electronic health records are digital versions of patients’ medical histories, including diagnoses, treatments, lab results, and medications, stored securely and accessible to authorized healthcare providers. The adoption of electronic health records is increasing primarily due to the growing emphasis on digitization in healthcare, which enhances efficiency, reduces errors, and enables seamless sharing of patient information among providers. Dose tracking copilot integrates with electronic health records by enabling seamless sharing of patient medication data, making it beneficial for healthcare providers managing multiple patients. It reduces manual data entry and improves accuracy by automatically syncing dosing information, enhancing clinical decision-making and overall patient care. For instance, in June 2022, according to the Department of Health and Social Care, a UK-based government department, approximately 90% of NHS trusts had adopted electronic health records by December 2023 and were expected to reach 100% adoption by March 2025. Therefore, the rising adoption of electronic health records is driving the growth of the dose tracking copilot market.
The rising healthcare expenditure is expected to propel the growth of the dose tracking copilot market going forward. Healthcare expenditure refers to the total amount of financial resources spent on healthcare services, including medical treatments, hospital care, medications, and public health initiatives, by governments, businesses, and individuals. The increasing healthcare expenditure is due to the rising prevalence of chronic diseases, which require long-term and costly treatments. Rising healthcare expenditure supports dose tracking copilot by driving investment in digital health solutions, making advanced medication management tools more accessible. These tools reduce the risk of medication errors and improve patient outcomes by enabling precise dose monitoring, supporting overall healthcare efficiency. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, with a 0.9% growth compared to 2022. Therefore, the rising healthcare expenditure is driving the growth of the dose tracking copilot market.
Major companies operating in the dose tracking copilot market are Medisafe Inc, AiCure Inc, etectRx Inc, Adherium Limited, Hero Health Inc, Pillsy Inc, Mango Health Inc, Proteus Digital Health Inc, CareZone Inc, WellDoc Inc, HealthBeacon plc, Smart Pill Technologies Inc, DoseTrak Systems Inc, RxCap Inc, CuePath Innovation Inc, MedMinder Systems Inc, Chrono Therapeutics Inc, SMRxT Inc, InHandPlus Inc, Pillsure Pocket Inc.
North America was the largest region in the dose tracking copilot market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dose tracking copilot market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dose tracking copilot market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the dose tracking copilot market by increasing costs of software infrastructure, servers, monitoring hardware, and connected devices. Cloud-based and hardware-integrated solutions are most affected, particularly in regions dependent on imported electronics such as North America and Europe. However, tariffs are also accelerating local software development, cloud adoption, and scalable digital health innovations.
The dose tracking copilot market research report is one of a series of new reports that provides dose tracking copilot market statistics, including dose tracking copilot industry global market size, regional shares, competitors with a dose tracking copilot market share, detailed dose tracking copilot market segments, market trends and opportunities, and any further data you may need to thrive in the dose tracking copilot industry. This dose tracking copilot market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A dose tracking copilot refers to a digital health tool designed to support individuals or patients in accurately managing and monitoring their medication intake. It functions as an intelligent assistant that records doses, sends reminders, and helps maintain adherence to prescribed schedules. The copilot often evaluates usage patterns, notifies users of missed or incorrect doses, and can connect with wearables or smart devices for real-time tracking. It may also document symptoms or side effects, enabling users and healthcare providers to make informed decisions.
The key components of a dose tracking copilot include software, hardware, and services. Software refers to digital platforms and applications that track, monitor, and manage patient doses, offer analytics, integrate with healthcare systems, and support clinical decision-making and compliance. It is deployed through on-premises and cloud-based modes and is used in radiology, nuclear medicine, oncology, cardiology, and other fields. Key end-users include hospitals, diagnostic centers, ambulatory surgical centers, research institutes, and others.
The dose tracking copilot market consists of revenues earned by entities by providing services such as digital medication tracking, dose scheduling and reminders, real-time adherence monitoring, patient data analytics, personalized dosing recommendations, and integration with healthcare provider systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The dose tracking copilot market also includes sales of medication reminder apps, pill reminder devices, dose logging software sales, dose monitoring wearables, and digital medication logbooks. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The dose tracking copilot market size is expected to see rapid growth in the next few years. It will grow to $2.99 billion in 2030 at a compound annual growth rate (CAGR) of 17%. The growth in the forecast period can be attributed to AI-driven clinical decision support, remote patient management growth, regulatory focus on dose monitoring, personalized treatment pathways, cloud-based healthcare platforms. Major trends in the forecast period include medication adherence monitoring, intelligent dose reminder systems, real-time dose analytics, patient-centric digital health tools, integration with wearables.
The increasing prevalence of chronic diseases is expected to propel the growth of the dose tracking copilot market going forward. Chronic diseases are long-lasting health conditions that usually progress slowly over time, such as diabetes, heart disease, and arthritis, and often require ongoing medical attention and lifestyle management to control symptoms and prevent complications. Chronic diseases are rising largely due to unhealthy lifestyles, including poor diet, physical inactivity, and smoking, which increase the risk of conditions such as diabetes, heart disease, and obesity. Dose tracking copilot supports chronic disease management by providing real-time monitoring and personalized dose reminders, making it suitable for patients with complex medication schedules. It reduces the risk of missed or incorrect doses by enabling accurate adherence tracking, improving treatment effectiveness and overall patient outcomes. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing prevalence of chronic diseases is driving the growth of the dose tracking copilot market.
The rising adoption of electronic health records (EHRs) is expected to propel the growth of the dose tracking copilot market going forward. Electronic health records are digital versions of patients’ medical histories, including diagnoses, treatments, lab results, and medications, stored securely and accessible to authorized healthcare providers. The adoption of electronic health records is increasing primarily due to the growing emphasis on digitization in healthcare, which enhances efficiency, reduces errors, and enables seamless sharing of patient information among providers. Dose tracking copilot integrates with electronic health records by enabling seamless sharing of patient medication data, making it beneficial for healthcare providers managing multiple patients. It reduces manual data entry and improves accuracy by automatically syncing dosing information, enhancing clinical decision-making and overall patient care. For instance, in June 2022, according to the Department of Health and Social Care, a UK-based government department, approximately 90% of NHS trusts had adopted electronic health records by December 2023 and were expected to reach 100% adoption by March 2025. Therefore, the rising adoption of electronic health records is driving the growth of the dose tracking copilot market.
The rising healthcare expenditure is expected to propel the growth of the dose tracking copilot market going forward. Healthcare expenditure refers to the total amount of financial resources spent on healthcare services, including medical treatments, hospital care, medications, and public health initiatives, by governments, businesses, and individuals. The increasing healthcare expenditure is due to the rising prevalence of chronic diseases, which require long-term and costly treatments. Rising healthcare expenditure supports dose tracking copilot by driving investment in digital health solutions, making advanced medication management tools more accessible. These tools reduce the risk of medication errors and improve patient outcomes by enabling precise dose monitoring, supporting overall healthcare efficiency. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, with a 0.9% growth compared to 2022. Therefore, the rising healthcare expenditure is driving the growth of the dose tracking copilot market.
Major companies operating in the dose tracking copilot market are Medisafe Inc, AiCure Inc, etectRx Inc, Adherium Limited, Hero Health Inc, Pillsy Inc, Mango Health Inc, Proteus Digital Health Inc, CareZone Inc, WellDoc Inc, HealthBeacon plc, Smart Pill Technologies Inc, DoseTrak Systems Inc, RxCap Inc, CuePath Innovation Inc, MedMinder Systems Inc, Chrono Therapeutics Inc, SMRxT Inc, InHandPlus Inc, Pillsure Pocket Inc.
North America was the largest region in the dose tracking copilot market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dose tracking copilot market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dose tracking copilot market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the dose tracking copilot market by increasing costs of software infrastructure, servers, monitoring hardware, and connected devices. Cloud-based and hardware-integrated solutions are most affected, particularly in regions dependent on imported electronics such as North America and Europe. However, tariffs are also accelerating local software development, cloud adoption, and scalable digital health innovations.
The dose tracking copilot market research report is one of a series of new reports that provides dose tracking copilot market statistics, including dose tracking copilot industry global market size, regional shares, competitors with a dose tracking copilot market share, detailed dose tracking copilot market segments, market trends and opportunities, and any further data you may need to thrive in the dose tracking copilot industry. This dose tracking copilot market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A dose tracking copilot refers to a digital health tool designed to support individuals or patients in accurately managing and monitoring their medication intake. It functions as an intelligent assistant that records doses, sends reminders, and helps maintain adherence to prescribed schedules. The copilot often evaluates usage patterns, notifies users of missed or incorrect doses, and can connect with wearables or smart devices for real-time tracking. It may also document symptoms or side effects, enabling users and healthcare providers to make informed decisions.
The key components of a dose tracking copilot include software, hardware, and services. Software refers to digital platforms and applications that track, monitor, and manage patient doses, offer analytics, integrate with healthcare systems, and support clinical decision-making and compliance. It is deployed through on-premises and cloud-based modes and is used in radiology, nuclear medicine, oncology, cardiology, and other fields. Key end-users include hospitals, diagnostic centers, ambulatory surgical centers, research institutes, and others.
The dose tracking copilot market consists of revenues earned by entities by providing services such as digital medication tracking, dose scheduling and reminders, real-time adherence monitoring, patient data analytics, personalized dosing recommendations, and integration with healthcare provider systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The dose tracking copilot market also includes sales of medication reminder apps, pill reminder devices, dose logging software sales, dose monitoring wearables, and digital medication logbooks. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Dose Tracking Copilot Market Characteristics
3. Dose Tracking Copilot Market Supply Chain Analysis
4. Global Dose Tracking Copilot Market Trends and Strategies
5. Dose Tracking Copilot Market Analysis of End Use Industries
7. Global Dose Tracking Copilot Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Dose Tracking Copilot Total Addressable Market (TAM) Analysis for the Market
9. Dose Tracking Copilot Market Segmentation
10. Dose Tracking Copilot Market Regional and Country Analysis
11. Asia-Pacific Dose Tracking Copilot Market
12. China Dose Tracking Copilot Market
13. India Dose Tracking Copilot Market
14. Japan Dose Tracking Copilot Market
15. Australia Dose Tracking Copilot Market
16. Indonesia Dose Tracking Copilot Market
17. South Korea Dose Tracking Copilot Market
18. Taiwan Dose Tracking Copilot Market
19. South East Asia Dose Tracking Copilot Market
20. Western Europe Dose Tracking Copilot Market
21. UK Dose Tracking Copilot Market
22. Germany Dose Tracking Copilot Market
23. France Dose Tracking Copilot Market
24. Italy Dose Tracking Copilot Market
25. Spain Dose Tracking Copilot Market
26. Eastern Europe Dose Tracking Copilot Market
27. Russia Dose Tracking Copilot Market
28. North America Dose Tracking Copilot Market
29. USA Dose Tracking Copilot Market
30. Canada Dose Tracking Copilot Market
31. South America Dose Tracking Copilot Market
32. Brazil Dose Tracking Copilot Market
33. Middle East Dose Tracking Copilot Market
34. Africa Dose Tracking Copilot Market
36. Dose Tracking Copilot Market Competitive Landscape and Company Profiles
37. Dose Tracking Copilot Market Other Major and Innovative Companies
40. Dose Tracking Copilot Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Dose Tracking Copilot Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses dose tracking copilot market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for dose tracking copilot? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dose tracking copilot market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Software; Services2) By Deployment: On-Premises; Cloud-Based
3) By Application: Clinical Cardiac Monitoring; Remote Patient Monitoring; Sports and Fitness Monitoring; Preventive and Wellness Monitoring; Rehabilitation and Post-Surgery Care; Research and Clinical Studies
Subsegments:
1) By Software: Dose Management Software; Integration And Interoperability Modules; Compliance And Reporting Tools; Clinical Decision Support Systems2) By Services: Implementation And Integration Services; Training And Education Services; Maintenance And Support Services; Consulting And Workflow Optimization; Cloud Hosting And Managed Services
Companies Mentioned: Medisafe Inc; AiCure Inc; etectRx Inc; Adherium Limited; Hero Health Inc; Pillsy Inc; Mango Health Inc; Proteus Digital Health Inc; CareZone Inc; WellDoc Inc; HealthBeacon plc; Smart Pill Technologies Inc; DoseTrak Systems Inc; RxCap Inc; CuePath Innovation Inc; MedMinder Systems Inc; Chrono Therapeutics Inc; SMRxT Inc; InHandPlus Inc; Pillsure Pocket Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Dose Tracking Copilot market report include:- Medisafe Inc
- AiCure Inc
- etectRx Inc
- Adherium Limited
- Hero Health Inc
- Pillsy Inc
- Mango Health Inc
- Proteus Digital Health Inc
- CareZone Inc
- WellDoc Inc
- HealthBeacon plc
- Smart Pill Technologies Inc
- DoseTrak Systems Inc
- RxCap Inc
- CuePath Innovation Inc
- MedMinder Systems Inc
- Chrono Therapeutics Inc
- SMRxT Inc
- InHandPlus Inc
- Pillsure Pocket Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.6 Billion |
| Forecasted Market Value ( USD | $ 2.99 Billion |
| Compound Annual Growth Rate | 17.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
